Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/26/2003WO2003030920A9 An antispasmodic agent spaced drug delivery system
06/26/2003WO2003030820A3 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae
06/26/2003WO2003029272A3 A method of treating schizophrenia and bipolar disorders
06/26/2003WO2003028648A3 Veterinaire florfenicol formulation that is syringeable under cold weather conditions
06/26/2003WO2003026612A3 Dosage forms having an inner core and outer shell
06/26/2003WO2003026610A3 Process for the preparation of fast dissolving dosage form
06/26/2003WO2003026576A3 Induction of brown adipocytes by transcription factor nfe2l2
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003WO2002098352A3 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
06/26/2003WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
06/26/2003WO2002090515A3 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
06/26/2003WO2002069971A8 Pharmaceutical compositions and dietary supplements for treatment or improvement of arthitis
06/26/2003WO2002069369A3 Cpg-like nucleic acids and methods of use thereof
06/26/2003WO2002065834A8 Novel formulations of carvedilol
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002060340A3 Method for identifying maxi-k channel blockers
06/26/2003WO2002058733A3 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
06/26/2003WO2002047611A8 Cddo-compounds and combination therapies thereof
06/26/2003WO2002018608A3 Methods for enhancing the efficacy of cancer therapy
06/26/2003WO2002017900A3 Modulators of us28 (chemokines) for treating cytomegalovirus infections
06/26/2003WO2001097778A8 Amphotericin b structured emulsion
06/26/2003WO2001066551A8 Azole compounds as therapeutic agents for fungal infections
06/26/2003US20030120306 Method and apparatus for the detection and occlusion of blood vessels
06/26/2003US20030120093 Reacting cytotoxic hydrofuranoxanthones with palladium complex and benzoquinone in presence of dimethyl sulfoxide; antiproliferative/antitumor agents; topoisomerase inhibitors; downregulating oncogenes
06/26/2003US20030120081 Process for the preparation of non-steroidal glucocorticoid receptor modulators
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030120076 Vitreous form
06/26/2003US20030120074 Cardioprotective phosphonates and malonates
06/26/2003US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders
06/26/2003US20030120071 Chemical compounds
06/26/2003US20030120070 Serotonin 5-HT1A and dopamin D2 receptor ligands
06/26/2003US20030120069 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease
06/26/2003US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives
06/26/2003US20030119956 An oil in water emulsion comprising an alkaline to increase the solubility of aza compound; control infestations, infections of livestock or domestic animals; topical application, veterinary medicine
06/26/2003US20030119916 Treatment of functional gastrointestinal disorders
06/26/2003US20030119915 (-)-Pseudoephedrine as a sympathomimetic drug
06/26/2003US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents
06/26/2003US20030119913 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
06/26/2003US20030119911 Levothyroxine sodium and liothyronine sodium in solid form with microcrystalline cellulose; treating hypothyroidism and thyroid hormone replacement therapy
06/26/2003US20030119910 Therapeutic or preventing agent for diseases caused by decrease in the expression level of klotho protein
06/26/2003US20030119909 Stabilized medicament containing cysteinyl derivatives
06/26/2003US20030119908 Stable gabapentin compositions
06/26/2003US20030119907 Accelerating uncoupled respiration and proton leak of the inner membrane of mitochondria which are induced by uncoupling proteins usingcoupled isomerized highly unsaturated fatty acids
06/26/2003US20030119906 Pharmaceutical forms for the oral administration of mesna
06/26/2003US20030119905 Contacting the bone marrow with an inhibitor of nitric oxide synthase, to produce bone marrow having an increased population of hematopoietic stem cells capable of normal hematopoiesis and differentiation
06/26/2003US20030119904 Solid, crystalline, non-hygroscopic acetyl L-carnitine fumarate; boiling point 0f 105-110 degrees c
06/26/2003US20030119903 Use of trimebutine for treating pain
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119901 Phenylene ethers with a benzamidine group; leukotriene b4 (ltb4)
06/26/2003US20030119900 Ureas, amides, and carbamates; dicyclohexyl urea
06/26/2003US20030119898 6-96 mu g of a 7-hydroxy-cyclopenta-3-one(b)pyran derivatives
06/26/2003US20030119897 Cd45 inhibitors
06/26/2003US20030119896 Chondrogenesis promoters and indolin-2-one derivatives
06/26/2003US20030119895 Anticancer agents
06/26/2003US20030119894 Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells
06/26/2003US20030119893 Non-selective beta-blocker with a vasodilating component
06/26/2003US20030119892 Methods and compositions for treating headache pain with topical NSAID compositions
06/26/2003US20030119891 Polylactam oligomers of N-methyl-2-carboxy-4-imidazole, N-methyl-2-carboxy-4-aminopyrrole modified by 4-aminobutyric acid, 3-amino-propionic acid and 3-(dimethylamino)propylamine binding specifically to the cyclogenase 2 gene
06/26/2003US20030119889 1,3-Disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis
06/26/2003US20030119888 Composition comprising l-arginine as a muscle growth stimulant and use thereof
06/26/2003US20030119887 Lactacystin analogs
06/26/2003US20030119885 1,2-Diaminocyclopentanes, e.g., N-(2-(3-(4-chlorophenyl)-propylamino)cyclopentyl)-2-(5-(3,4 -dimethoxyphenyl)pyrimidin-2-ylsulfanyl)acetamide; inhibit eosinphil recruitment; skindisorders; asthma; antiinflammatory agents, antiallergens
06/26/2003US20030119884 Methods and compositions for regulating memory consolidation
06/26/2003US20030119882 Solid pharmaceutical composition containing torasemide
06/26/2003US20030119881 Antivirals
06/26/2003US20030119880 Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors
06/26/2003US20030119879 Nicotine replacement therapy including tobacco substitution and smoking cessation; rapid transmucosal absorption of nicotine; oral and nasal drug delivery; rapid absorption; bioavailability; taste-masking; dosage; Alzheimer's
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119877 Pyridine derivatives useful as cyclooxygenase inhibitor
06/26/2003US20030119875 Arzoxifene hydrochloride and a stabilizer selected from methionine, acetylcysteine, cysteine or salts thereof; oxidation resistance; storage stability; anticarcinogenic agents; cardiovascular disorders; osteoporosis; Alzheimer's
06/26/2003US20030119874 Method for enhancing mutant enzyme activity in gaucher disease
06/26/2003US20030119873 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
06/26/2003US20030119872 Process for preparing non-hygroscopic sodium valproate composition
06/26/2003US20030119870 2-(Pyrid-2- or 4-yl)-1,2,3,4-tetrahydroisoquinoline and derivatives; a good affinity to the NMDA receptor (N-methyl-D-asparate); acute/cronic neurodegenerative diseases; bacterial/viral infections; antidepressants; analgesics
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119868 Gyrase inhibitors and uses thereof
06/26/2003US20030119867 Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
06/26/2003US20030119866 Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
06/26/2003US20030119865 Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
06/26/2003US20030119864 Farnesyl transferase inhibitors
06/26/2003US20030119862 Pharmaceutical combination
06/26/2003US20030119860 Administering to the mammal suffering from non-rheumatoid arthritis a therapeutically effective amount of a secretory phospholiase A2 (sPLA2) inhibitors to treat rheumatoid (an indole compound)
06/26/2003US20030119859 Useful in the prophylaxis and treatment of respiratory diseases
06/26/2003US20030119858 Conformationally constrained compounds as pharmaceutical agents
06/26/2003US20030119857 Pyrimidinyl methyl indole derivatives with antibacterial activity
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119854 Compounds and methods for modulating CXCR3 function
06/26/2003US20030119853 Thiocarboxamide derivatives
06/26/2003US20030119852 Pyridine or pyrimidine compounds containing C(=O or =S)-N-S(O)m=o,1,2 group, used as insecticides, fungicides, miticides and parasiticides
06/26/2003US20030119851 In the treatment or prevention of psychotic disorders such as schizophrenia psychotic depression, mania and other central nervous system diseases
06/26/2003US20030119849 Piperazine and piperidine compounds
06/26/2003US20030119848 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
06/26/2003US20030119847 Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1
06/26/2003US20030119846 Compounds with 5-ht activity useful for controlling visual field loss
06/26/2003US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119843 Tricycloheteroaromic ring containing imidazole compounds used as farnesyl transferase and geranylgeranyl transferase inhibitor
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003US20030119841 Treatment and prevention of anxiety and convulsive disorders
1 ... 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 ... 7860